Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
A requirement to secure hyrdoxychloroquine tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Blackrock Pharmaceuticals Ltd | 06458588 | ~£0 estimated from lot values | - |